Cargando…

Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses

Statin use has been linked with new-onset diabetes mellitus (NODM). In the present systematic review, we aimed to determine the incidence of NODM with statin use by assessing and summarizing the data generated by different systematic reviews and metaanalyses published on this topic. We conducted a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Harmanjit, Sikarwar, Pallavi, Khurana, Supreet, Sharma, Jatin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835812/
https://www.ncbi.nlm.nih.gov/pubmed/36694884
http://dx.doi.org/10.17925/EE.2022.18.2.96
_version_ 1784868744215920640
author Singh, Harmanjit
Sikarwar, Pallavi
Khurana, Supreet
Sharma, Jatin
author_facet Singh, Harmanjit
Sikarwar, Pallavi
Khurana, Supreet
Sharma, Jatin
author_sort Singh, Harmanjit
collection PubMed
description Statin use has been linked with new-onset diabetes mellitus (NODM). In the present systematic review, we aimed to determine the incidence of NODM with statin use by assessing and summarizing the data generated by different systematic reviews and metaanalyses published on this topic. We conducted a systematic review of systematic reviews and meta-analyses using a pre-defined study protocol. Two authors independently performed a literature search using PubMed, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL) for studies reporting data on statin use and NODM incidence and screened and extracted data for the outcomes of interest. The Assessing the Methodological Auality of Systematic Reviews 2 (AMSTAR 2) checklist was used to evaluate the quality of the included systematic reviews and meta-analyses. The initial search yielded 621 potential records, and 16 relevant systematic reviews and meta-analyses were included in the present systematic review. The included studies showed an increase in the risk of NODM with statin use. In particular, rosuvastatin and atorvastatin were associated with NODM in many systematic reviews or meta-analyses; however, pravastatin and pitavastatin were found to be associated with lower or no risk. We observed a positive trend of development of NODM with statin use became more evident with advancing years as more number of studies were added. Intensive doses of statins and use in older subjects were found to be important risk factors for NODM. Finally, the quality assessment revealed that the included systematic reviews and metaanalyses were of critically low or low quality. We concluded that statin use carries a risk of causing NODM. Statins should not be discouraged in anticipation of NODM. However, glycaemic monitoring should be encouraged with the on-going statin therapy. Furthermore, clinical studies addressing the use of statins and the incidence of NODM as their primary objective should be planned.
format Online
Article
Text
id pubmed-9835812
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Touch Medical Media
record_format MEDLINE/PubMed
spelling pubmed-98358122023-01-23 Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses Singh, Harmanjit Sikarwar, Pallavi Khurana, Supreet Sharma, Jatin touchREV Endocrinol Diabetes Statin use has been linked with new-onset diabetes mellitus (NODM). In the present systematic review, we aimed to determine the incidence of NODM with statin use by assessing and summarizing the data generated by different systematic reviews and metaanalyses published on this topic. We conducted a systematic review of systematic reviews and meta-analyses using a pre-defined study protocol. Two authors independently performed a literature search using PubMed, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL) for studies reporting data on statin use and NODM incidence and screened and extracted data for the outcomes of interest. The Assessing the Methodological Auality of Systematic Reviews 2 (AMSTAR 2) checklist was used to evaluate the quality of the included systematic reviews and meta-analyses. The initial search yielded 621 potential records, and 16 relevant systematic reviews and meta-analyses were included in the present systematic review. The included studies showed an increase in the risk of NODM with statin use. In particular, rosuvastatin and atorvastatin were associated with NODM in many systematic reviews or meta-analyses; however, pravastatin and pitavastatin were found to be associated with lower or no risk. We observed a positive trend of development of NODM with statin use became more evident with advancing years as more number of studies were added. Intensive doses of statins and use in older subjects were found to be important risk factors for NODM. Finally, the quality assessment revealed that the included systematic reviews and metaanalyses were of critically low or low quality. We concluded that statin use carries a risk of causing NODM. Statins should not be discouraged in anticipation of NODM. However, glycaemic monitoring should be encouraged with the on-going statin therapy. Furthermore, clinical studies addressing the use of statins and the incidence of NODM as their primary objective should be planned. Touch Medical Media 2022-11 2022-11-29 /pmc/articles/PMC9835812/ /pubmed/36694884 http://dx.doi.org/10.17925/EE.2022.18.2.96 Text en © Touch Medical Media 2022 ali:free_to_read www.copyright.com (http://www.copyright.com) Author contributions: Both Harmanjit Singh and Pallavi Sikarwar are first authors on the paper. Review process: Double-blind peer review. Compliance with ethics: This study involves a review of the literature and did not involve any studies with human or animal subjects performed by any of the authors. Data availability: Data sharing is not applicable to this article as no datasets were generated or analysed during the writing of this study. Authorship: The named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published. https://creativecommons.org/licenses/by/3.0/Access: This article is freely accessible at touchENDOCRINOLOGY.com (http://touchENDOCRINOLOGY.com) . © Touch Medical Media 2022
spellingShingle Diabetes
Singh, Harmanjit
Sikarwar, Pallavi
Khurana, Supreet
Sharma, Jatin
Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses
title Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses
title_full Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses
title_fullStr Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses
title_full_unstemmed Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses
title_short Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses
title_sort assessing the incidence of new-onset diabetes mellitus with statin use: a systematic review of the systematic reviews and meta-analyses
topic Diabetes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835812/
https://www.ncbi.nlm.nih.gov/pubmed/36694884
http://dx.doi.org/10.17925/EE.2022.18.2.96
work_keys_str_mv AT singhharmanjit assessingtheincidenceofnewonsetdiabetesmellituswithstatinuseasystematicreviewofthesystematicreviewsandmetaanalyses
AT sikarwarpallavi assessingtheincidenceofnewonsetdiabetesmellituswithstatinuseasystematicreviewofthesystematicreviewsandmetaanalyses
AT khuranasupreet assessingtheincidenceofnewonsetdiabetesmellituswithstatinuseasystematicreviewofthesystematicreviewsandmetaanalyses
AT sharmajatin assessingtheincidenceofnewonsetdiabetesmellituswithstatinuseasystematicreviewofthesystematicreviewsandmetaanalyses